Isolation and characterization of a biosurfactant producing strain, Brevibacilis brevis HOB1.
Biosurfactant-producing bacteria were isolated from the production water of an oil field. Isolates were screened for biosurfactant production using surface tension test. The highest reduction of surface tension was achieved with a bacterial strain which was identified by 16S rRNA gene sequencing as Brevibacilis brevis HOB1. It has been investigated using different carbon and nitrogen sources. It showed that the strain was able to grow and reduce the surface tension of the broth to 29 mN/m on commercial sugar and maltose, and to 32 mN/m on glucose after 72 h of growth. The maximum amount of biosurfactant was obtained when nitrate ions were supplied as nitrogen source. Biosurfactant produced by Brevibacilis brevis HOB1 was confirmed as a lipopeptide class of biosurfactant using TLC test and mass spectra. Lipopeptide isoforms were isolated from cell-free supernatants by acid-precipitation followed by one step of chromatographic separation on solid-phase ODS C18 column. The separation was confirmed by HPLC and ESI Q-TOF MS spectroscopy. Comparing the mass data obtained and the mass numbers reported for the lipopeptide complexes from other strains, it can be concluded that the major lipopeptide product of Brevibacilis brevis HOB1 is the surfactin isoform. This lipopeptide showed strong antibacterial and antifungal activity. It is a candidate for the biocontrol of pathogens in agriculture and other industries.
Haddad
Namir I A
NI
College of Chemistry and Molecular Engineering, East China University of Science and Technology, 200237, Shanghai, China. Namir.haddad@gmail.com
Wang
Ji
J
Mu
Bozhong
B
D001419:Bacteria / Q000302:isolation & purification* / Q000378:metabolism; D055666:Lipopeptides / Q000096:biosynthesis*; D013500:Surface Tension; D013501:Surface-Active Agents / Q000378:metabolism*
D055666:Lipopeptides; D013501:Surface-Active Agents
Curr Med Chem. 2004 Aug;11(16):2105-34
15279552
Nat Protoc. 2008;3(2):153-62
18274516
Biotechnology (N Y). 1992 Jan;10(1):60-5
1368190
Appl Microbiol Biotechnol. 2000 May;53(5):495-508
10855707
Trends Biotechnol. 2004 Mar;22(3):142-6
15036865
In Vitro Cell Dev Biol Anim. 1997 Jun;33(6):414-5
9201506
Microbiol Res. 1994 Sep;149(3):241-6
7987612
J Ind Microbiol. 1991 Jan;7(1):45-52
1367206
Int J Cosmet Sci. 1991 Apr;13(2):61-4
19291045
Appl Environ Microbiol. 1981 Sep;42(3):408-12
16345840
Curr Opin Microbiol. 2004 Jun;7(3):262-6
15196493
J Bacteriol. 1993 Oct;175(20):6459-66
8407822
Biotechnol Adv. 1985;3(1):65-83
14541779
Trends Biotechnol. 1992 Jun;10(6):208-17
1368395
Appl Environ Microbiol. 2002 Dec;68(12):6210-9
12450846
Protein Pept Lett. 2007;14(8):766-73
17979816
Chem Pharm Bull (Tokyo). 1972 Jul;20(7):1551-7
4640448
Appl Microbiol Biotechnol. 1999 May;51(5):553-63
10390813
Biochem Biophys Res Commun. 1968 May 10;31(3):488-94
4968234
Biochemistry. 1991 Jul 2;30(26):6503-8
1905154
Appl Biochem Biotechnol. 2004 Spring;113-116:899-912
15054241
Appl Environ Microbiol. 1986 Mar;51(3):661-3
16347027
Nucleic Acids Res. 1997 Sep 1;25(17):3389-402
9254694
Appl Microbiol Biotechnol. 1991 Oct;36(1):5-13
1367776
Biochem Biophys Res Commun. 2007 Dec 7;364(1):53-9
17931599
Biotechnol Appl Biochem. 1990 Aug;12(4):370-5
2119191
J Colloid Interface Sci. 1998 Aug 1;204(1):1-8
9665760
Protein Pept Lett. 2008;15(3):265-9
18336355